INDV

Indivior
INDV

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
£867.07M
EV
£910.21M
Shares Outstanding
124.76M
Beta
0.32

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£14.43
P/E 2025E
8.18x
P/Revenue 2025E
1.13x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Indivior PLC

gainify
INDV

Indivior PLC

INDV

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. T...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Crossley, Mark

Employees

1,041

IPO Date

2014-12-22

Headquarters

10710 Midlothian Turnpike, Suite 125, North Chesterfield, Virginia, 23235, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved